Cyclerion competitorsClear all

Cyclerion's top competitors include Reata Pharmaceuticals, Ironwood Pharmaceuticals, Biogen and Inovio Pharmaceuticals.
Cyclerion
Cyclerion
Cyclerion Therapeutics is a biopharmaceutical company specializing in soluble guanylate cyclase (sGC) pharmacology.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.
Founding Date
Founding Date
2019
Founding Date
2002
Founding Date
N/A
Founding Date
1978
Founding Date
1979
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Ely, GB HQ
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
Cambridge, US HQ
Boston, US
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
Mississauga, CA
see more
Locations
Plymouth Meeting, US HQ
San Diego, US
San Diego, US
Employees
Employees
94
Employees
22079% increase
Employees
31738% decrease
Employees
7,4005% decrease
Employees
2811% increase
Valuation ($)
Valuation ($)
130.4 m
Valuation ($)
4.4 b
Valuation ($)
1.5 b
Valuation ($)
41.6 b
Valuation ($)
2.3 b
Twitter followers
Twitter followers
263
Twitter followers
1.1 k
Twitter followers
3.7 k
Twitter followers
37.1 k
Twitter followers
18.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
48
Number of tweets (last 30 days)
3
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.5
Average likes per tweet (last 30 days)
1.4
Average likes per tweet (last 30 days)
12.3
Average likes per tweet (last 30 days)
186
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
88.24%
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
95.83%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
267694
Alexa Website Rank
264292
Alexa Website Rank
286247
Alexa Website Rank
289178
Alexa Website Rank
163792
Employee Rating
Employee Rating
4.7
Employee Rating
3.9
Employee Rating
4
Employee Rating
4.2
Employee Rating
3.5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$26.5m (FY, 2019)
Revenue (est.)
$389.5m (FY, 2020)
Revenue (est.)
$13.4b (FY, 2020)
Revenue (est.)
$4.1m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$3.1m (FY, 2020)
Cost of goods
$1.8b (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$386.4m (FY, 2020)
Gross profit
$11.6b (FY, 2020)
Gross profit
N/A
Net income
Net income
N/A
Net income
($290.2m) (FY, 2019)
Net income
$106.2m (FY, 2020)
Net income
$4.1b (FY, 2020)
Net income
($120.6m) (FY, 2019)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
240 (FY, 2016)
Patents Issued
N/A
Patents Issued
34 (FY, 2019)
Patents Issued
620 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
13 (Q3, 2020)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
9 (Q3, 2020)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
6 (Q3, 2020)
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 175m
Total funding raised
$ 468.9m
Total funding raised
$ 609m
Total funding raised
N/A
Total funding raised
$ 202.6m
For sources of this data, please see the company profile

View company profiles

Reata Pharmaceuticals
HQ
Plano, US
Employees
220

Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
317↓ 38% decrease

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company
Biogen
HQ
Cambridge, US
Employees
7,400↓ 5% decrease

Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
Inovio Pharmaceuticals
HQ
Plymouth Meeting, US
Employees
281↑ 1% increase

Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.

View company